Medicine and Dentistry
Thrombus
100%
Deep Vein Thrombosis
78%
Magnetic Resonance Imaging
58%
Phlebothrombosis
53%
Stenting
48%
Post-Thrombotic Syndrome
40%
Revascularization
38%
Limb
38%
Endovascular Aneurysm Repair
35%
Critical Limb Ischemia
34%
Atherosclerosis
32%
DNA Damage
27%
Diseases
26%
Venous Stent
25%
Inferior Vena Cava
24%
Vein Blood Flow
22%
Vein Wall
22%
Hypoxia Inducible Factor 1
22%
Radiation Exposure
21%
Blood Clot Lysis
21%
Obstruction
20%
Thorax Outlet Syndrome
19%
Vein Disease
18%
Upregulation
18%
Hypoxia
18%
Thrombosis
16%
Contrast Medium
16%
Neutrophil
16%
Recanalization
15%
Upper Limb
14%
Lymphocyte
14%
Thromboembolism
13%
Venous Circulation
13%
Nitinol
13%
Thoracoabdominal Aorta Aneurysm
13%
Infection
13%
X-Ray Microtomography
13%
Inflammatory Cell
12%
Macrophage
11%
Platelet
11%
Venous Ulcer
11%
Leukocyte
11%
Albumin
11%
Venous Thromboembolism
11%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
11%
Blood Clotting
11%
Antiangiogenic Therapy
11%
Elastin
10%
Aneurysm
10%
Ischemia
10%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombus
56%
Deep Vein Thrombosis
29%
Neovascularization (Pathology)
27%
Vein Thrombosis
22%
Critical Limb Ischemia
18%
Postthrombosis Syndrome
14%
Hypoxia Inducible Factor 1
12%
Angiogenic Factor
12%
Clinical Study
12%
Ulcer
11%
Mouse Model
10%
Thromboembolism
10%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
10%
Radiation Exposure
9%
Albumin
9%
Preclinical Study
9%
Inflammation
9%
Antioxidant
9%
Nuclear Magnetic Resonance Imaging Agent
9%
Disease Marker
9%
Venous Thromboembolism
9%
Urokinase Receptor
9%
Reactive Oxygen Metabolite
9%
Hypoxia
9%
Peripheral Occlusive Artery Disease
9%
Acetylsalicylic Acid
9%
Antithrombocytic Agent
9%
Antiangiogenic Therapy
9%
2-Methoxyestradiol
8%
Clopidogrel
8%
Gadofosveset
6%
Contrast Medium
6%
Thoracoabdominal Aorta Aneurysm
6%
Number Needed to Treat
6%
Angiogenesis Inhibitor
5%